Effect of ellagic acid on proliferation, cell adhesion and apoptosis in SH-SY5Y human neuroblastoma cells

Biomedicine and Pharmacotherapy

Volumn 63, Issue 4, 2009, Pages 254-261

  Fjaeraa, Christina ^a   Nånberg, Eewa ^a  

^a KARLSTAD UNIVERSITY   (Sweden)

Author keywords

Apoptosis; Ellagic acid; Neuroblastoma

Indexed keywords

DIMETHYL SULFOXIDE; ELLAGIC ACID; RETINOIC ACID;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL CULTURE; CELL CYCLE ARREST; CELL DEATH; CELL PROLIFERATION; CELL STRAIN SH SY5Y; CELL VIABILITY; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; ELLAGIC ACID; GROWTH INHIBITORS; HUMANS; NEURITES; NEUROBLASTOMA; TRETINOIN; TUMOR STEM CELL ASSAY;

EID: 64749108144     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2008.07.093     Document Type: Article

References (38)

1. Liu R.H. Potential synergy of phytochemicals in cancer prevention: mechanisms of action. J Nutr 134 (2004) 3480S-3485S
2. Tsuda H., Ohshima T., Nomoto H., Fujita K.I., Matsuda E., Iigo M., et al. Cancer prevention by natural compounds. Drug Metab Pharmacokinet 19 (2004) 245-263
3. Borek C. Dietary antioxidants and human cancer. Integr Cancer Ther 3 (2004) 331-341
4. Steinmetz K.A., and Potter J.D. Vegetables, fruit, and cancer prevention: a review. J Am Diet Assoc 96 (1996) 1027-1039
5. Dorai T., and Aggarwal B.B. Role of chemopreventive agents in cancer therapy. Cancer Lett 215 (2004) 129-140
6. Pan M.H., Ghai G., and Ho C.T. Food bioactives, apoptosis, and cancer. Mol Nutr Food Res 52 (2008) 43-52
7. Singh R.P., Dhanalakshmi S., and Agarwal R. Phytochemicals as cell cycle modulators. Cell Cycle 1 (2002) 156-161
8. Cerdá B., Espín J.C., Parra S., Martínez P., and Tomás-Barberán F.A. The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivates by the colonic microflora of healthy humans. Eur J Nutr 43 (2004) 205-220
9. Espín J.C., Gonzáles-Barrio R., Cerdá B., López-Bote C., Rey A.I., and Tomás-Barberán F.A. Iberian pig as a model to clarify obscure points in the bioavailability and metabolism of ellagitannins in humans. J Agric Food Chem 55 (2007) 10476-10485
10. Mertens-Talcott S.U., Jilma-Stohlawetz P., Rios J., Hingorani L., and Derendorf H. Absorption, metabolism, and antioxidant effects of pomegranate (Punica granatum L.) polyphenols after ingestion of a standardized extract in healthy human volunteers. J Agric Food Chem 54 (2006) 8956-8961
11. Seeram N.P., Henning S.M., Zhang Y., Suchard M., Li Z., and Heber D. Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr 136 (2006) 2481-2485
12. Larrosa M., Thomás-Barberán F.A., and Espín J.C. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem 17 (2006) 611-625
13. Li T.M., Chen G.W., Su C.C., Lin J.G., Yeh C.C., Cheng K.C., et al. Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res 25 (2005) 971-979
14. Losso J.N., Bansode R.R., Trappey II A., Bawadi H.A., and Truax R. In vitro anti-proliferative activities of ellagic acid. J Nutr Biochem 15 (2004) 672-678
15. Narayanan B.A., Geoffroy O., Willingham M.C., Re G.G., and Nixon D.W. p53/p21 (WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett 136 (1999) 215-221
16. Seeram N.P., Adams L.S., Henning S.M., Niu Y., Zhang Y., Nair M.G., et al. In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem 16 (2005) 360-367
17. Aggarwal B.B., and Shishoida S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71 (2006) 1397-1421
18. Biedler J.L., Helson L., and Spengler B.A. Morphology and growth, tumorigenecity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33 (1973) 2643-2652
19. Odelstad L., Påhlman S., Nilsson K., Larsson E., Läckgren G., Johansson K.E., et al. Neuron-specific enolase in relation to differentiation in human neuroblastoma. Brain Res 224 (1981) 69-82
20. Olsson A.K., Vadhammar K., and Nånberg E. Activation and protein kinase C-dependent nuclear accumulation of ERK in differentiating human neuroblastoma cells. Exp Cell Res 256 (2000) 454-467
21. Landsverk K.S., Lyng H., and Stokke T. The response of malignant B lymphocytes to ionizing radiation: cell cycle arrest, apoptosis and protection against the cytotoxic effects of the mitotic inhibitor nocodazole. Radiat Res 162 (2004) 405-415
22. Stokke T., Solberg K., DeAngelis P., and Steen H.B. Propidium iodide quenches the fluorescence of TdT-incorporated FITC-labeled dUTP in apoptotic cells. Cytometry 33 (1998) 428-434
23. Påhlman S., Ruusala A.I., Abrahamsson L., Mattson M.E., and Esscher T. Retinoic acid-induced differentiation of cultured human neuroblastoma cells: a comparison with phorbolester-induced differentiation. Cell Differ 14 (1984) 135-144
24. Påhlman S., Hoehner J.C., Nånberg E., Hedborg F., Fagerström S., Gestblom C., et al. Differentiation and survival influences of growth factors in human neuroblastoma. Eur J Cancer 31A (1995) 453-458
25. Kim Y.J., Kim Y.S., Kim M.S., and Ryu J.C. The inhibitory mechanism of methylmercury on differentiation of human neuroblastoma cells. Toxicology 234 (2007) 1-9
26. Prince J.A., and Oreland L. Staurosporine differentiated human SH-SY5Y neuroblastoma cultures exhibit transient apoptosis and trophic factor independence. Brain Res Bull 43 (1997) 515-523
27. Guzhova I., Hultquist A., Cetinkaya C., Nilsson K., Påhlman S., and Larsson L.G. Interferon-γ cooperates with retinoic acid and phorbol ester to induce differentiation and growth inhibition of human neuroblastoma cells. Int J Cancer 94 (2001) 97-108
28. Lasorella A., Iavarone A., and Israel M.A. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance. Cancer Res 55 (1995) 4711-4716
29. Tieu K., Zuo D.M., and Yu P.H. Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins. J Neurosci Res 58 (1999) 426-435
30. Wainwright L.J., Lasorella A., and Iavarone A. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells. Proc Natl Acad Sci U S A 98 (2001) 9396-9400
31. Mertens-Talcott S.U., Bomser J.A., Romero C., Talcott S.T., and Percival S.S. Ellagic acid potentiates the effect of quercetin on p21waf1/cip1, p53 and MAP-kinases without affecting intracellular generation of reactive oxygen species in vitro. J Nutr 135 (2004) 609-614
32. Mertens-Talcott S.U., and Percival S.S. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 218 (2005) 141-151
33. Mertens-Talcott S.U., Talcott S.T., and Percival S.S. Low concentrations of quercetin and ellagic acid synergistically influence proliferation, cytotoxicity and apoptosis in MOLT-4 human leukemia cells. J Nutr 133 (2003) 2669-2674
34. Valentijn A.J., Zouq N., and Gilmore A.P. Anoikis. Biochem Soc Trans 32 (2004) 421-425
35. Boix J., Llecha N., Yuste V.J., and Comella J.X. Characterization of the cell death process induced by staurosporine in human neuroblastoma cell lines. Neuropharmacology 36 (1997) 811-821
36. Ronca F., Chan S.L., and Yu V.C. 1-(5-Isoquinolinesulfonyl)-2-methylpiperazine induces apoptosis in human neuroblastoma cells, SH-SY5Y, through a p53-dependent pathway. J Biol Chem 272 (1997) 4252-4260
37. Seidenfaden R., and Hildebrandt H. Retinoic acid-induced changes in polysialyltransferase mRNA expression and NCAM polysialylation in human neuroblastoma cells. J Neurobiol 46 (2001) 11-28
38. Linnala A., Lehto V.P., and Virtanen I. Neuronal differentiation in SH-SY5Y human neuroblastoma cells induces synthesis and secretion of tenascin and upregulation of alpha(v) integrin receptors. J Neurosci Res 49 (1997) 53-63